# COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID)

> **NCT04384588** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Fundacion Arturo Lopez Perez** · enrollment: 100 (estimated)

## Conditions studied

- COVID-19 Infection
- Cancer Patients
- General Population

## Interventions

- **BIOLOGICAL:** Convalescent Plasma from COVID-19 donors

## Key facts

- **NCT ID:** NCT04384588
- **Lead sponsor:** Fundacion Arturo Lopez Perez
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-07
- **Primary completion:** 2021-04-06
- **Final completion:** 2021-04-06
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-05-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04384588

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04384588, "COVID19-Convalescent Plasma for Treating Patients With Active Symptomatic COVID 19 Infection (FALP-COVID)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT04384588. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*